Verge HealthTech Fund is a global early-stage VC fund focusing exclusively on impactful healthtech. Verge has invested in 30+ healthtech startups across 6 continents, impacting over 27 million lives. Verge is anchored by Johnson & Johnson Foundation, Merck, Global Health Investment Corp, and supported by institutions, corporates and family offices. Unlike traditional healthcare funds, Verge doesn’t invest in biotech, invasive medtech, or asset-heavy infrastructure. Instead, we focus on high potential, scalable technologies including deeptech (next-gen diagnostics, breakthrough devices and AI) and platforms (digital health, digital therapeutics, healthcare SaaS), transitioning from “Sickcare” to “Health + Care”. From an impact perspective, the fund was set up on the belief that outsized impact can be created by using technology to increase access, affordability and quality. Verge delivers two bottom lines in financial return and impact, without sacrificing one for the other.









